Pexiganan‐incorporated collagen matrices for infected wound‐healing processes in rat
- 30 March 2005
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 73A (3), 320-331
- https://doi.org/10.1002/jbm.a.30303
Abstract
The use of peptide-based drugs is limited by their rapid degradability and toxicity at high concentration during their therapeutic application. These problems could be managed by the use of a peptide delivery agent for sustained release in the site of action. Collagen is one of the most proven biomaterials of good biocompatibility with an exceptional ligand encapsulating property. In this work, we have shown that pexiganan, an antimicrobial, 22-amino-acid peptide could be incorporated and delivered to the wound-healing site against bacterial strains Pseudomonas aeruginosa and Staphylococcus aureus. The release profiles of pexiganan collagen films with different collagen concentration were studied. The release of pexiganan from 2.5% w/w of collagen film showed a sustainable activity over 72 h with effective antimicrobial concentrations. Pexiganan-incorporated collagen (PIC)-treated groups were compared with open wound (OW)- and collagen film (CF)-treated rats. PIC-treated animals showed a diminishing level of bacterial growth as compared with OW- and CF-treated animals. The biochemical parameters such as hydroxyproline, protein, DNA, uronic acid, hexosamine, SOD, and catalase content in the granulation tissue of the healing wound revealed increased proliferation of cells involved in tissue reconstruction in PIC-treated groups when compared with OW- and CF-treated groups. Furthermore, spectroscopic studies suggested that collagen structure is not perturbed by pexiganan incorporation. This study provides rationale for application of collagen membrane for antimicrobial peptide delivery in infected wounds. © 2005 Wiley Periodicals, Inc. J Biomed Mater Res 73A: 320–331, 2005Keywords
This publication has 43 references indexed in Scilit:
- Treatment of post-burns bacterial infections by Fenton reagent, particularly the ubiquitous multiple drug resistant Pseudomonas spp.Medical Hypotheses, 2003
- nNOS inhibition, antimicrobial and anticancer activity of the amphibian skin peptide, citropin 1.1 and synthetic modificationsEuropean Journal of Biochemistry, 2003
- Wound Microbiology and Associated Approaches to Wound ManagementClinical Microbiology Reviews, 2001
- Arnebin-1 Accelerates Normal and Hydrocortisone-Induced Impaired Wound Healing1Journal of Investigative Dermatology, 1999
- Kinetics ofin vitro drug release from chitosan/gelatin hybrid membranesJournal of Applied Polymer Science, 1998
- Anionic Collagen: Polymer Composites with Improved Dielectric and Rheological PropertiesArtificial Organs, 1998
- Cationic peptides: a new source of antibioticsTrends in Biotechnology, 1998
- Collagen-based devices for soft tissue repairJournal of Biomedical Materials Research, 1996
- Characterization and flow properties of lyotropic ultrahigh‐molar‐mass polysaccharide mesophasesMacromolecular Symposia, 1994
- Effects of granulocyte-macrophage colony-stimulating factor on wound contractionEuropean Journal of Clinical Microbiology & Infectious Diseases, 1994